Cryopreservation techniques for umbilical cord blood (UCB) have been b
ased on methods established for marrow (BM) and peripheral blood proge
nitor cells (PBPC) with varying degrees of success. The aim of this st
udy was to optimise cryopreservation of UCB haemopoietic cells based o
n sound cryopreservation principles, UCB samples were cryopreserved wi
th different combinations of DMSO and hydroxyethyl starch (HES) by a v
ariety of freezing protocols. After cooling at 1 degrees C/min in solu
tions containing 4% HES and various concentrations of DMSO there was a
dramatic fall in CD34(+) recovery from 85.4% (s.d. 28.4) to 12.2% (s.
d. 10.0) as DMSO concentration was reduced from 5 to 2.5%. Varying HES
concentration in solutions containing 5% DMSO did not have a signific
ant effect on CD34(+) cell recovery. Increasing cooling rate from 1 to
10 degrees C/min significantly reduced CD34(+) recovery (P < 0.0001)
while increasing DMSO concentration up to 10% had little effect (P = 0
.8, two-way ANOVA), Good recovery of UCB CD34(+) cells can be achieved
with 5-10% DMSO at a controlled cooling rate of 1 degrees C/min. Ther
e was a significant difference (P < 0.0001) in the apparent recovery o
f CD34(+) cells between paired aliquots thawed in the presence (recove
ry = 76.8%, s.d. 26.0) and absence (32.5%, s.d. 18.7) of DNase, In con
clusion, conditions for cryopreserving UCB for clinical banking that y
ield optimal recovery of CD34(+) cells have been established.